Actively Recruiting
Randomized Study on the Need for a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients Using Urine Genome-Wide Low-Depth Sequencing After Initial Surgery
Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2025-06-25
428
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, randomized clinical trial involving 428 patients with non-muscle-invasive bladder cancer NMIBC who have undergone initial transurethral resection and are scheduled for a second resection. The study aims to compare the necessity of a second resection in patients with negative urine genome-wide low-depth sequencing results after their initial surgery. The trial will evaluate two-year recurrence-free survival rates to assess the effectiveness of skipping the second resection in certain patients. Participants will provide a 100ml urine sample within 1 to 6 weeks after their first resection and before the second resection. This urine will be tested for DNA biomarkers. Patients with positive biomarker results will proceed with the second resection. Those with negative results will be randomly assigned to either skip the second resection or receive the standard second resection. All participants will be followed for two years to monitor outcomes. During the study, researchers will monitor clinical information, pathology, and recurrence through follow-up assessments. The primary outcome is the two-year recurrence-free survival rate, measuring the time from the initial surgery to the first confirmed recurrence within two years. The study also evaluates the predictive ability of the urine test for recurrence. Participants will be observed over two years to ensure safety and gather long-term data on cancer recurrence.
CONDITIONS
Brief Title
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
Research Team
Y
Yang xiao, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here